Navigation Links
Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
Date:5/20/2009

FRAZER, Pa., May 20 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it intends to offer, subject to market and other conditions, $300 million of common stock and $350 million in aggregate principal amount of convertible senior subordinated notes due 2014 through two concurrent public offerings. Cephalon will grant the underwriters a 30-day option, solely to cover over-allotments, to purchase up to an additional $45 million of common stock, with respect to the common stock offering, and to purchase up to an additional $52.5 million in aggregate principal amount of the notes, with respect to the notes offering.

The notes will be convertible into cash and, if applicable, shares of Cephalon's common stock based on a conversion rate to be determined. The interest rate, conversion price and other terms of the notes will be determined at the time of pricing of the offering by negotiations between Cephalon and the underwriters. The notes will be subordinate to existing and future senior indebtedness, equal to existing and future senior subordinated indebtedness and senior in right of payment to existing and future subordinated indebtedness of Cephalon.

The offerings are being made pursuant to an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission. For each offering, a prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the U.S. Securities and Exchange Commission. Neither of these offerings is contingent upon the consummation of the other offering.

Cephalon intends to use a portion of the net proceeds of the notes offering to enter into a hedging transaction on its common stock with Deutsche Bank AG, London Branch (the "hedge counterparty"), an affiliate of the representative
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cephalons New Product Launches Pace Record 2008 Sales
2. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
3. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
4. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
5. Cephalon, Inc. to Webcast Analyst Day
6. Cephalon Reports Another Strong Quarter
7. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
8. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
9. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
10. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
11. Cephalon Quarterly Conference Call Invitation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 /PRNewswire-FirstCa...Board: MZEI) announced today that in tests involvi...continues to break "6 log" decontamination barrier... bacteria, Claustridium difficile and Bacillis sub...(TM) as an extremely potent sporicidal technology....
(Date:12/1/2009)... , ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -...the "Company"), an Atlanta-based, biopharmaceutica...aused by HIV-1 (Human Immunodeficiency Virus) and ...rt for World AIDS Day. ,, "Today is the 21st Wo...have lost their fight with the HIV/AIDS pandemic, ...
(Date:12/1/2009)... A new clinical study present...ne shows that three-dimensional (3-D) automated ul...oftware during an in vitro fertilization (IVF) cyc...l manual measurement of the follicles. , ...9 -- The Advanced Fertility Center of Chicago has ...
(Date:12/1/2009)... iCardiac now provides servic... companies. , Rochester, ...es, Inc., a global leader in advanced cardiac core...t a top five pharmaceutical company has selected i...ices. iCardiac will provide Highly Automated QT(s...
Breaking Biology Technology:Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2
...ate economy , , ALEXANDRIA, Va., May 7 Today, t...t request, proposing level funding for the Carl D....ns Act) at $1.3 billion. The Perkins Act is the pr...l education programs that connect education and re...echnical Education (ACTE) and the National Associa...
...n (Nasdaq: SIAL ) will be presenting at the Bank...erence on Wednesday, May 13th at 2:00 PM Eastern D...ties may listen via live audio broadcast over the ...ich.com/ . Users can click the "Webcast" icon to...igma-Aldrich is a leading Life Science and High Te...
...wd of more than 170 bioscience leaders at the Mich...tephen Rapundalo, Ph.D., MichBio president and CEO...rs of the industry,s economic growth potential has...otechnology as part of the Senate,s Economic Devel...s a House Subcommittee focused on biosciences as p...
Other Biology Technology:Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3Sigma-Aldrich to Present at the Bank of America and Merrill Lynch 2009 Healthcare Conference on Wednesday, May 13, 2009 2MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of State's Growing Awareness of Industry's Economic Importance 2MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of State's Growing Awareness of Industry's Economic Importance 3MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of State's Growing Awareness of Industry's Economic Importance 4
(Date:12/2/2009)..., REDWOOD SHORES, Calif. and PALM HARBOR, Fla.,...telligence Corporation ("CIC") (OTC Bulletin Board...e solutions for business process automation in the...n biometric signature verification and Docubase Sy...lectronic Document Management (EDM) software provi...
(Date:12/2/2009)...d nanotubescylinders of carbon about a nanometer i...plications such as ultrastrong fibers, electrical ...mponents for fuel cells. Thanks to a new developme...ndards and Technology (NIST) and five partners, yo...ion and destruction of an aggressive form of breas...
(Date:12/2/2009)...from the University of Salamanca and another from ...edators affects the behaviour of Acanthodactylus ...sert in the Near East. According to the study, the...fferent prey if they are under pressure from preda...is result, but until now there had been very few e...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Lizards change their diet to avoid predators 2Hard To Treat Diseases 28HTDS PK 29 To Regain Intellectual Property 28IP 29 Ownership 49873 1Hard To Treat Diseases 28HTDS PK 29 To Regain Intellectual Property 28IP 29 Ownership 49873 2Hard To Treat Diseases 28HTDS PK 29 To Regain Intellectual Property 28IP 29 Ownership 49873 3Elizabeth Edwards to Deliver Keynote Address at Patient Advocate Foundations 10th Annual Patient Congress 49870 1Elizabeth Edwards to Deliver Keynote Address at Patient Advocate Foundations 10th Annual Patient Congress 49870 2Zix Corporation Addresses New HIPAA Regulations 49867 1Zix Corporation Addresses New HIPAA Regulations 49867 2Zix Corporation Addresses New HIPAA Regulations 49867 3
... is a poorly understood condition that incapacitat...illions of women around the world. In the US, it a...ents at a cost of some $1.6 billion per year. It ...ometrial tissue grows as lesions outside the uteru... tubes, but can also affect the intestinal tract. ...
...) are major contributors to morbidity and mortalit...ochemical, and genetic risk factors can increase d...olved in the etiology of CVD are known, many are y...scientists have searched for these genes with geno...more targeted candidate gene studies. , Master of...
...ediatrics, edited and sponsored by the National In...hysicians will have access in one place to the rev...l, behavioral, and environmental changes during ch..., maintenance, and acceleration of illegal use of ...ollection of where science is in our understanding...
Other Biology News:Where college students live can impact their weight, eating and exercise habits 2Where college students live can impact their weight, eating and exercise habits 3Genetic variants of USF1 are associated with the increased risk for cardiovascular disease 2Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 2Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 3Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 4
Flexi Rabbit Reticulocyte Lysate System from Promega
10% Normal Goat Serum from Invitrogen
Pyrophosphate Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
m7G(5)ppp(5)G (Cap Analog) from Ambion
Biology Products: